MAZE
Maze Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$26.21
+1.31%Leverage
- Debt / equity
- 0.13x
- Net debt / equity
- -0.31x
- Debt / assets
- 0.11x
- Debt / EBITDA
- -0.46x
- Net debt / EBITDA
- 1.09x
Liquidity & coverage
- Current ratio
- 18.31x
- Quick ratio
- 18.31x
- Cash ratio
- 17.90x
- Interest coverage
- -81.03x
- EBITDA / interest
- -72.50x
- Working capital
- $397.5M
Cash & dividend
- FCF / debt
- -1.77x
- Cash flow / debt
- -1.76x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026